Evidence map›Paper›PMID 35266570›Full record

ReviewAllergy2022

Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines?

Bernadette Eberlein, Sonja Mathes, Jörg Fischer, Ulf Darsow, Tilo Biedermann, Knut Brockow

Open access · hybridAbstract readReview
In one paragraph

Review in Allergy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. PEG allergy - A COVID-19 pandemic-made problem? A German perspective.The World Allergy Organization journal · 2022
    Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Bernadette EberleinDepartment of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany.ORCID 0000-0003-4509-6491
Sonja MathesDepartment of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany.
Jörg FischerDepartment of Dermatology, Eberhard Karls University, Tübingen, Germany.
Ulf DarsowDepartment of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany.
Tilo BiedermannDepartment of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany.
Knut BrockowDepartment of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany.ORCID 0000-0002-2775-3681
Technical University of Munich · DECarl von Ossietzky Universität Oldenburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The worldwide use of COVID-19 vaccines has shown that immediate allergic reactions to the ingredients are rare but should be clarified by means of an allergological work-up. This review aims to highlight the current state of knowledge and possible pathogenesis based on the literature published to date. In addition to recording a detailed history and performing skin tests, cellular tests (basophil activation or basophil histamine release test) by using the vaccines or modified compounds containing polyethylene glycol (PEG), rather than unmodified PEGs, have proven to be particularly helpful. Negative results with vaccines seem to indicate tolerance. Details of the performance of these cellular tests with different vaccines, PEGs of different molecular weights, other ingredients of the vaccines, as well as other PEGylated drugs, and the results in the context of COVID-19 vaccination of various working groups worldwide are summarized.

Indexed as

COVID-19COVID-19 VaccinesHypersensitivityBasophil Degranulation TestHumansPolyethylene GlycolsCOVID-19 VaccinesPolyethylene Glycolsbasophil activation testbasophil histamine release testCOVID-19 vaccinesmRNA vaccinespolyethylene glycol (PEG)

Identifiers

PMID35266570
PMCPMC9111482
OpenAlexW4220976304

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.